Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)
Open Access

The Overlap Index as a means of evaluating early tau-PET signal reliability

Jeyeon Lee, Brian J. Burkett, Hoon-Ki Min, Emily S. Lundt, Sabrina M. Albertson, Hugo Botha, Matthew L. Senjem, Jeffrey L. Gunter, Christopher G Schwarz, David G Jones, David S. Knopman, Clifford R. Jack, Ronald C. Petersen and Val J. Lowe
Journal of Nuclear Medicine March 2022, jnumed.121.263136; DOI: https://doi.org/10.2967/jnumed.121.263136
Jeyeon Lee
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian J. Burkett
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hoon-Ki Min
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily S. Lundt
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina M. Albertson
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugo Botha
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew L. Senjem
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey L. Gunter
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher G Schwarz
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David G Jones
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David S. Knopman
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clifford R. Jack Jr.
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald C. Petersen
2 Mayo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Val J. Lowe
1 Mayo Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

In tau positron emission tomography (tau-PET), a reliable method to detect early tau accumulation in the brain is crucial. Noise, artifacts, and off-target uptake impede detection of subtle true positive ligand binding. We hypothesize that identifying voxels with stable activity over time can enhance detection of true positive tau. Methods: 339 participants in the clinical spectrum ranging from clinically unimpaired to Alzheimer’s Disease Dementia underwent ≥2 serial tau-PET scans with flortaucipir. The “overlap index” (OI) method was proposed to detect spatially identical, voxel-wise standardized uptake value ratio (SUVR) elevation when seen sequentially in serial tau-PET scans. The association of OI with tau accumulation, clinical diagnosis, and cognitive findings was evaluated. Results: OI showed good dynamic range in the low-SUVR window. Only OI was able to identify subgroups with increasing tau-PET signal in low SUVR meta-ROI groups. OI showed improved association with early clinical disease progression and cognitive scores versus meta-ROI SUVR measures. Conclusion: OI was more sensitive to tau signal elevation and longitudinal change than standard ROI measures, suggesting it is a more sensitive method for detecting early, subtle deposition of neurofibrillary tangles.

  • Image Processing
  • Molecular Imaging
  • PET
  • AV-1451
  • Flortaucipir
  • Tau PET
  • Variability
  • early detection

Footnotes

  • Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: https://jnm.snmjournals.org/page/permissions.

  • Copyright © 2022 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Overlap Index as a means of evaluating early tau-PET signal reliability
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Overlap Index as a means of evaluating early tau-PET signal reliability
Jeyeon Lee, Brian J. Burkett, Hoon-Ki Min, Emily S. Lundt, Sabrina M. Albertson, Hugo Botha, Matthew L. Senjem, Jeffrey L. Gunter, Christopher G Schwarz, David G Jones, David S. Knopman, Clifford R. Jack, Ronald C. Petersen, Val J. Lowe
Journal of Nuclear Medicine Mar 2022, jnumed.121.263136; DOI: 10.2967/jnumed.121.263136

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Overlap Index as a means of evaluating early tau-PET signal reliability
Jeyeon Lee, Brian J. Burkett, Hoon-Ki Min, Emily S. Lundt, Sabrina M. Albertson, Hugo Botha, Matthew L. Senjem, Jeffrey L. Gunter, Christopher G Schwarz, David G Jones, David S. Knopman, Clifford R. Jack, Ronald C. Petersen, Val J. Lowe
Journal of Nuclear Medicine Mar 2022, jnumed.121.263136; DOI: 10.2967/jnumed.121.263136
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • 18F-Fluorodihydroxyphenylalanine PET/CT at the Forefront for Initial and/or Pre-surgical Evaluation of Small Intestine Neuroendocrine Tumors
  • First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic
  • Safety and efficacy of holmium-166 radioembolization in hepatocellular carcinoma – the HEPAR Primary study
Show more Clinical Investigations (Human)

Clinical (Neurology)

  • Radionuclide Evaluation of Brain Death in the Post-McMath Era, epilogue and enigmata.
  • 18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy
  • Differential diagnosis of parkinsonism based on deep metabolic imaging indices
Show more Clinical (Neurology)

Similar Articles

Keywords

  • Image Processing
  • Molecular Imaging
  • PET
  • AV-1451
  • flortaucipir
  • Tau PET
  • Variability
  • early detection
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire